Gene therapy startup MeiraGTx files for $86M IPO – FierceBiotech
FierceBiotech |
Gene therapy startup MeiraGTx files for $86M IPO
FierceBiotech MeiraGTx has filed for an $86 million IPO to advance a handful of gene therapies into and through clinical trials. The transatlantic biotech is initially targeting inherited retinal diseases with therapies designed to halt vision loss. MeiraGTx was … |
